BioSpace News Archive

Policy

Pfizer Pushes Officials to Approve COVID-19 Vaccine Booster Shot

The data may show the need for one, but vaccine and immunologists are pushing back against Pfizer and BioNTech’s contention that one is necessary now.

July 13, 2021
·
4 min read
·
Mark Terry
Man vs. Machine – Which is Best at Predicting Clinical Trial Outcomes?

A recent Deny-Colton Virtual Salon pitted human intelligence against AI/ML to weigh not just the outcomes, but the process.

July 13, 2021
·
5 min read
·
Gail Dutton
Business

Biogen Scoops Up Exclusive Rights to Chinese Molecule for MS

The license and collaboration agreement center on orelabrutinib, an oral small molecule BTKi characterized by its high selectivity and the ability to cross the blood-brain barrier.

July 13, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Biotech Uncloaks Primed for ‘Search and Replace’ Gene Editing with $315 Million

The company’s technology aims to precisely search out genetic mutations at their precise genome location, limiting concerns about toxicities or unwanted cellular changes.

July 13, 2021
·
3 min read
·
Alex Keown
BioMidwest

Ohio State Researchers Use Gene Therapy to Treat Children with Rare AADC Disease

A new study has found potential in a novel gene therapy method to help children born with the rare genetic and neurodegenerative disorder, AADC deficiency.

July 13, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

China’s CRISPR Babies Propel WHO to Issue Global Standards for Gene Editing

The WHO panel recommends adopting global standards, giving structure to prevent the unscrupulous, inequitable, and possibly dangerous uses of CRISPR technology.

July 13, 2021
·
3 min read
·
Kate Goodwin
Policy

COVID-19 News: WHO Warns Against Mixing and Matching Vaccines and More

The U.S. appears to be beating back COVID-19 but it’s still raging in many parts of the world, and studies and trials are still ongoing. Here’s a look at some of today’s top COVID-19 stories.

July 13, 2021
·
3 min read
·
Mark Terry
Business

Pneumococcal Vaccine Snags Breakthrough Therapy Designation

The vaccine candidate ASP3772 generated an antibody response to each of the 24 polysaccharides in its makeup and antibody response to the two conserved pneumococcal proteins.

July 13, 2021
·
2 min read
·
Alex Keown
Drug Development

Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021

Highly specific HDAC6 inhibitors (HDAC6i) demonstrated improved cardiac function in mouse models of heart failure with preserved ejection in fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM)

July 13, 2021
·
3 min read
Business

Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.

Hillstream BioPharma, Inc. today announced the expansion of the Scientific Advisory Board (SAB) with the addition of Scott J. Dixon, Ph.D. , Associate Professor, Biology, Stanford University.

July 13, 2021
·
5 min read